Analysis on the Development of Chinese Biopharmaceutical Industry

DOI

10.2991/aebmr.k.220306.017How to use a DOI?

Keywords

Biopharmaceuticals industry; Pharmaceutical engineering; Development trend analysis; Innovation

Abstract

Known as the “never ending sunrise industry”, the biopharmaceutical industry is one of the most important strategic emerging industries in China. Entering the 21st century, with the rapid development of science and technology, the biopharmaceutical industry has also witnessed tremendous rapid development. Bioengineering pharmaceutical technology combines the advantages of biology, medicine and microbiology. Biotechnology is widely used in various fields of pharmaceutical engineering, including genetic engineering, cell engineering and fermentation engineering. From the current state of development, although China’s biopharmaceutical industry has made significant progress, there are still many areas that need to be improved and strengthened, especially in terms of innovation. First, many companies lack incentives and thus lack innovative talents. Second, most biopharmaceutical companies have little awareness of voluntary innovation and invest a large amount of capital and human resources in high-yield, low-risk, low-cost generics. Finally, the domestic market of pharmaceutical companies appears to be characterized by being small, scattered and disorganized, thus leading to an uneven development of core technologies. Based on the statistical analysis of recent years, some suggestions for changing the status quo and achieving innovative breakthroughs are proposed to elaborate the further innovative development of biopharmaceutical enterprises in the future.

Copyright

© 2022 The Authors. Published by Atlantis Press International B.V.

Open Access

This is an open access article under the CC BY-NC license.

Download article (PDF)

TY  - CONF
AU  - Pengfei Ji
PY  - 2022
DA  - 2022/03/17
TI  - Analysis on the Development of Chinese Biopharmaceutical Industry
BT  - Proceedings of the 7th International Conference on Economy, Management, Law and Education (EMLE 2021)
PB  - Atlantis Press
SP  - 106
EP  - 112
SN  - 2352-5428
UR  - https://doi.org/10.2991/aebmr.k.220306.017
DO  - 10.2991/aebmr.k.220306.017
ID  - Ji2022
ER  -